Chargement en cours...
CD30-targeting drugs: cure for mastocytosis?
New promising targets and targeted drugs for treatment of aggressive forms of systemic mastocytosis are few; in this issue of Blood, Blatt et al(1) provide evidence that aberrant Ki-1 antigen (CD30) expression on neoplastic mast cells may serve as a therapeutic target of brentuximab-vedotin alone or...
Enregistré dans:
| Publié dans: | Blood |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4692137/ https://ncbi.nlm.nih.gov/pubmed/26705339 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-11-678631 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|